Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).

被引：0
|
作者：
Puerto, VL
Cardenas, J
Lara, F
Goana, R
Silva, A
Barroso, N
机构：
[1] IMSS CMN Siglo XXI, Mexico City, DF, Mexico
[2] Ctr Estatal Cancerol, Colima, Mexico
[3] INCAN, Tlalpan, Mexico
[4] Hosp Gen Dr M Silva, Morelia, Michoacan, Mexico
[5] Hosp Dr A Leano, Zapopan, Mexico
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
512
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [31] Changes in Ki67 expression and clinical response to neoadjuvant chemotherapy in locally advanced breast cancer (LABC)
    Devi, Desak Gede Agung Pramesti
    Purwanto, Heru
    Sandhika, Willy
    BALI MEDICAL JOURNAL, 2021, 10 (03) : 925 - 931
  • [32] Epirubicin and Docetaxel as Primary Chemotherapy in Locally Advanced Breast Cancer
    Conti, F.
    Corsetti, S.
    Viola, G.
    Sperduti, I.
    Carpano, S.
    Pizzuti, L.
    Foggi, P.
    Perri, P.
    Anza, M.
    Toglia, G.
    Lopez, M.
    ONCOLOGY, 2009, 77 : 139 - 140
  • [33] BMI and TLC Influences Doxorubicin/Epirubicin Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer
    Priyono, Sasongko Hadi
    Putra, Oscar Tri Joko
    Yasmina, Alfi
    Poerwosusanta, Hery
    Rahman, Eka Yudha
    Oktaviyanti, Ika Kustiyah
    MAJALAH KEDOKTERAN BANDUNG, 2022, 54 (04): : 221 - 227
  • [34] A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer
    Villman, Kenneth
    Ohd, John F.
    Lidbrink, Elisabet
    Malmberg, Lena
    Lindh, Birgitta
    Blomqvist, Carl
    Nordgren, Hans
    Bergh, Jonas
    Bergstrom, Daniel
    Ahlgren, Johan
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1153 - 1160
  • [35] Neoadjuvant chemotherapy in locally advanced breast cancer.
    Soraya, Sami Sahnoun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Neoadjuvant chemotherapy for male with locally advanced breast cancer
    Murashko, R.
    Keshabyan, A.
    Zandaryan, A.
    Stepanov, A.
    BREAST, 2019, 44 : S69 - S69
  • [37] NEOADJUVANT 3-WEEKLY EPIRUBICIN (EPI) PLUS DOCETAXEL (DOC) CHEMOTHERAPY (CT) IN LOCALLY ADVANCED BREAST CANCER (LABC): ACTIVITY, SAFETY AND PREDICTIVE FACTORS OF RESPONSE
    Strada, Maria Rosa
    Frascaroli, Mara
    Palumbo, Raffaella
    Bernardo, Antonio
    Villani, Laura
    Scelsi, Mario
    Jedrychowska, Ivona
    Albanese, Davide
    Teragni, Cristina
    Bernardo, Giovanni
    ANNALS OF ONCOLOGY, 2009, 20
  • [38] Antiangiogenic effect of taxane chemotherapy in the treatment of locally advanced breast cancer (LABC).
    Masterson, J
    Wu, DW
    Sarta, C
    Malik, U
    Sparano, J
    Fineberg, S
    MODERN PATHOLOGY, 2001, 14 (01) : 31A - 31A
  • [39] Antiangiogenic effect of taxane chemotherapy in the treatment of locally advanced breast cancer (LABC).
    Masterson, J
    Wu, DW
    Sarta, C
    Malik, U
    Sparano, J
    Fineberg, S
    LABORATORY INVESTIGATION, 2001, 81 (01) : 31A - 31A
  • [40] Neoadjuvant chemotherapy with gemcitabine(G), epirubicin(E), and paclitaxel(T) in locally advanced breast cancer(LABC): A phase II trial of the NSABP Foundation Research Group.
    Hamm, J
    Wilson, J
    Lembersky, BC
    Robidoux, A
    Raymond, J
    Kardinal, C
    DiNunno, L
    Melemed, A
    Geyer, CE
    Paik, S
    Wolmark, N
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S53 - S53
12345